Pharmaceutical Development Program Strategy & Pre-Clinical Clinical Development Regulatory Market Access Commercialization Quality & Compliance Advisory, Transformation & Design The Source
Drug Substance Development (API)
Drug Product Development​
Manufacturing Operations
Manufacturing Compliance
Development Strategy​
Program Evaluation
Non-Clinical Study Execution
Non-Clinical Regulatory Submissions
Non-Clinical Compliance
Clinical Development Strategy
Clinical Operations & Study Management​
Medical Writing & Regulatory Submissions
Clinical Compliance​
Pre-Approval
Authoring, Publishing & Submissions
Post-Approval
Functional Outsourcing
Special Projects
Strategy Development
Achieving Market Access
Artwork & Labeling​
Distribution
Product Release Process
Pre-Approval Inspections & Vendor Audits
Good Laboratory Practice (GLP)
Good Clinical Practice (GCP)
Good Manufacturing Practice (GMP)
Inspection Readiness
Organizational Assessment, Strategy & Design
Implementation, Excellence & Transformation
M&A Regulatory Due Diligence & Integration
Digital Technology Advisory
Case Studies
Regulatory Affairs FAQs Our Brochure
Career Opportunities Contract Opportunities
Select your language
  • Go back
  • Drug Substance Development (API)
  • Drug Product Development​
  • Manufacturing Operations
  • Manufacturing Compliance
  • Go back
  • Development Strategy​
  • Program Evaluation
  • Non-Clinical Study Execution
  • Non-Clinical Regulatory Submissions
  • Non-Clinical Compliance
  • Go back
  • Clinical Development Strategy
  • Clinical Operations & Study Management​
  • Medical Writing & Regulatory Submissions
  • Clinical Compliance​
  • Go back
  • Pre-Approval
  • Authoring, Publishing & Submissions
  • Post-Approval
  • Functional Outsourcing
  • Special Projects
  • Go back
  • Strategy Development
  • Achieving Market Access
  • Go back
  • Artwork & Labeling​
  • Distribution
  • Product Release Process
  • Pre-Approval Inspections & Vendor Audits
  • Go back
  • Good Laboratory Practice (GLP)
  • Good Clinical Practice (GCP)
  • Good Manufacturing Practice (GMP)
  • Inspection Readiness
  • Go back
  • Organizational Assessment, Strategy & Design
  • Implementation, Excellence & Transformation
  • M&A Regulatory Due Diligence & Integration
  • Digital Technology Advisory
    • Contact Us

    Talk to an expert. Get in touch.

    © 2024 G&L Scientific

    Select your language

    Stephen Loughrey

    Stephen Loughrey

    Chief Executive Officer

    Biography

    Stephen Loughrey is the CEO and Co-Founder of G&L Scientific, a global leader in Regulatory Affairs consultancy. 

    With over 25 years of experience, Stephen pioneered the evolution of the Functional Service Provider (FSP) model for the life sciences sector. 

    Under his leadership, G&L received the 2022 Queen's Award for Enterprise and the 2024 King’s Award for Enterprise, recognizing the company’s excellence in international trade and its expansion into 100+ global markets. 

    Stephen is a frequent contributor to global regulatory forums and specializes in scaling technical workforces for complex, multi-market drug submissions.